Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiomics features as predictive and prognostic biomarkers in NSCLC.
Bortolotto C, Lancia A, Stelitano C, Montesano M, Merizzoli E, Agustoni F, Stella G, Preda L, Filippi AR. Bortolotto C, et al. Among authors: lancia a. Expert Rev Anticancer Ther. 2021 Mar;21(3):257-266. doi: 10.1080/14737140.2021.1852935. Epub 2020 Dec 4. Expert Rev Anticancer Ther. 2021. PMID: 33216651 Review.
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy.
Mazzola R, Jereczek-Fossa BA, Franceschini D, Tubin S, Filippi AR, Tolia M, Lancia A, Minniti G, Corradini S, Arcangeli S, Scorsetti M, Alongi F. Mazzola R, et al. Among authors: lancia a. Radiat Oncol. 2020 May 4;15(1):92. doi: 10.1186/s13014-020-01544-0. Radiat Oncol. 2020. PMID: 32366258 Free PMC article. Review.
Radiotherapy in the era of COVID-19.
Lancia A, Bonzano E, Bottero M, Camici M, Catellani F, Ingrosso G. Lancia A, et al. Expert Rev Anticancer Ther. 2020 Aug;20(8):625-627. doi: 10.1080/14737140.2020.1785290. Epub 2020 Jul 7. Expert Rev Anticancer Ther. 2020. PMID: 32552073 No abstract available.
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series.
Francolini G, Detti B, Bottero M, Zilli T, Lancia A, Bruni A, Borghesi S, Mariotti M, Castellucci P, Fanti S, Filippi AR, Teriaca MA, Maragna V, Aristei C, Mazzeo E, Livi L, Ingrosso G. Francolini G, et al. Among authors: lancia a. Clin Transl Oncol. 2021 Feb;23(2):364-371. doi: 10.1007/s12094-020-02427-2. Epub 2020 Jun 29. Clin Transl Oncol. 2021. PMID: 32602076
From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective.
Accordino G, Lettieri S, Bortolotto C, Benvenuti S, Gallotti A, Gattoni E, Agustoni F, Pozzi E, Rinaldi P, Primiceri C, Morbini P, Lancia A, Stella GM. Accordino G, et al. Among authors: lancia a. Cancers (Basel). 2020 Jul 29;12(8):2105. doi: 10.3390/cancers12082105. Cancers (Basel). 2020. PMID: 32751137 Free PMC article. Review.
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells.
Sun R, Sundahl N, Hecht M, Putz F, Lancia A, Rouyar A, Milic M, Carré A, Battistella E, Alvarez Andres E, Niyoteka S, Romano E, Louvel G, Durand-Labrunie J, Bockel S, Bahleda R, Robert C, Boutros C, Vakalopoulou M, Paragios N, Frey B, Soria JC, Massard C, Ferté C, Fietkau R, Ost P, Gaipl U, Deutsch E. Sun R, et al. Among authors: lancia a. J Immunother Cancer. 2020 Nov;8(2):e001429. doi: 10.1136/jitc-2020-001429. J Immunother Cancer. 2020. PMID: 33188037 Free PMC article.
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: A systematic review.
Ingrosso G, Becherini C, Francolini G, Lancia A, Alì E, Caini S, Teriaca MA, Marchionni A, Filippi AR, Livi L, Sanguineti G, Aristei C, Detti B. Ingrosso G, et al. Among authors: lancia a. Crit Rev Oncol Hematol. 2021 Mar;159:103242. doi: 10.1016/j.critrevonc.2021.103242. Epub 2021 Feb 2. Crit Rev Oncol Hematol. 2021. PMID: 33545356 Review.
95 results